The Enterprise Value as of June 2026 (TTM) for Cabaletta Bio, Inc. (CABA) is 400.61M

According to Cabaletta Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 400.61M. This represents a change of 187.47% compared to the average of 139.36M of the last 4 quarters.

Cabaletta Bio, Inc. (CABA) Historical Enterprise Value (quarterly & annually)

How has CABA Enterprise Value performed in the past?

The mean historical Enterprise Value of Cabaletta Bio, Inc. over the last ten years is 172.15M. The current 400.61M Enterprise Value has changed 23.17% with respect to the historical average. Over the past ten years (40 quarters), CABA's Enterprise Value was at its highest in in the December 2023 quarter at 820.45M. The Enterprise Value was at its lowest in in the September 2022 quarter at -42303900.00.

Cabaletta Bio, Inc. (CABA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cabaletta Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cabaletta Bio, Inc. (CABA) Average Enterprise Value

How has CABA Enterprise Value performed in the past?

The current Enterprise Value of Cabaletta Bio, Inc. (CABA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cabaletta Bio, Inc. (CABA) Enterprise Value vs. Peers

How is CABA’s Enterprise Value compared to its peers?

Cabaletta Bio, Inc.’s Enterprise Value is greater than Editas Medicine, Inc. (193.08M), less than Allogene Therapeutics, Inc. (514.09M), less than Capricor Therapeutics, Inc. (1.10B), greater than Kyverna Therapeutics, Inc. (329.49M), greater than Lyell Immunopharma, Inc. (263.73M), greater than Atea Pharmaceuticals, Inc. (280.64M), greater than ProQR Therapeutics N.V. (63.64M), greater than Immutep Limited (-1323749.00), greater than Lexeo Therapeutics, Inc. Common Stock (278.74M), greater than Humacyte, Inc. (194.60M),

Build a custom stock screener for Cabaletta Bio, Inc. (CABA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cabaletta Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cabaletta Bio, Inc. (CABA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cabaletta Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.